Literature DB >> 23225672

No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies.

Weiling Katherine Yih, Eric Weintraub, Martin Kulldorff.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23225672     DOI： 10.1002/pds.3353

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  5 in total

1.  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

Authors:  Sarah A Mbaeyi; Catherine H Bozio; Jonathan Duffy; Lorry G Rubin; Susan Hariri; David S Stephens; Jessica R MacNeil
Journal:  MMWR Recomm Rep       Date:  2020-09-25

Review 2.  Current safety issues with quadrivalent meningococcal conjugate vaccines.

Authors:  Tanya R Myers; Michael M McNeil
Journal:  Hum Vaccin Immunother       Date:  2017-11-08       Impact factor: 3.452

3.  Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review.

Authors:  Tracy A Becerra-Culqui; Lina S Sy; Zendi Solano; Hung Fu Tseng
Journal:  Hum Vaccin Immunother       Date:  2020-12-17       Impact factor: 3.452

Review 4.  Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016.

Authors:  Tanya R Myers; Michael M McNeil; Carmen S Ng; Rongxia Li; Paige L Marquez; Pedro L Moro; Saad B Omer; Maria V Cano
Journal:  Vaccine       Date:  2020-07-31       Impact factor: 4.169

Review 5.  Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes?

Authors:  Nicola Principi; Susanna Esposito
Journal:  Front Public Health       Date:  2020-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.